VIVO Cannabis Inc. announced the launch of its newest medical cannabis product formulation: high-dose cannabidiol (CBD) oil under its Beacon MedicalTM brand. Beacon MedicalTM 2:100 high-dose CBD oil is a distillate-based cannabis oil containing 100 mg CBD and less than 2 mg tetrahydrocannabinol (THC). The entire family of Beacon MedicalTM oil products are formulated using a non-GMO, food-grade medium-chain triglycerides (MCT) carrier oil which results in the final product being both scentless and flavourless in taste.